0001179110-15-013306.txt : 20150911 0001179110-15-013306.hdr.sgml : 20150911 20150911172815 ACCESSION NUMBER: 0001179110-15-013306 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150909 FILED AS OF DATE: 20150911 DATE AS OF CHANGE: 20150911 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDFISCHER CARL CENTRAL INDEX KEY: 0001110780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 151104009 MAIL ADDRESS: STREET 1: 161 WEST 61ST STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 edgar.xml FORM 4 - X0306 4 2015-09-09 0 0001042074 CymaBay Therapeutics, Inc. CBAY 0001110780 GOLDFISCHER CARL C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BLVD, SUITE 130 NEWARK CA 94560 1 0 0 0 Common Stock 2015-09-09 4 S 0 13 2.76 D 28 I By Bay City Capital LLC Common Stock 2015-09-09 4 S 0 13844 2.76 D 29980 I By The Bay City Capital Fund II, L.P. Common Stock 2015-09-09 4 S 0 905 2.76 D 1959 I By The Bay City Capital Fund II Co-Investment Fund, L.P Common Stock 2015-09-10 4 S 0 15 2.71 D 13 I By Bay City Capital LLC Common Stock 2015-09-10 4 S 0 15474 2.71 D 14506 I By The Bay City Capital Fund II, L.P. Common Stock 2015-09-10 4 S 0 1011 2.71 D 948 I By The Bay City Capital Fund II Co-Investment Fund, L.P. Common Stock 2015-09-11 4 S 0 13 2.77 D 0 I By Bay City Capital LLC Common Stock 2015-09-11 4 S 0 14506 2.76 D 0 I By The Bay City Capital Fund II, L.P. Common Stock 2015-09-11 4 S 0 948 2.76 D 0 I By The Bay City Capital Fund II Co-Investment Fund, L.P. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The Reporting Person is a managing director of Bay City Capital LLC, The Bay City Capital Fund II, L.P. and The Bay City Capital Fund II Co-Investment Fund, L.P (collectively the "Bay City Capital Funds"), and has voting and investment control over the shares owned by the Bay City Capital Funds. The Reporting Person disclaims beneficial ownership of the shares owned by the Bay City Capital Funds except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.66 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.69 to $2.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Sujal Shah, by power of attorney 2015-09-11